Recent studies on cancer genomes have revealed that recurrent somatic mutations of genes encoding RNA splicing factors (e.g. SF3B1, U2AF1, SRSF2, ZRSR2) lead to altered splice site preferences, resulting in cancer-specific mis-splicing of genes. The gene discussed is SRSF2; the disease is cancer.